At JP Morgan, Mass Spec Vendors Sketch Clinical Proteomics Plans, Highlight Top-selling Systems | GenomeWeb

Several major mass spec vendors took the stage this week at the JP Morgan Healthcare Conference in San Francisco, highlighting strong sales of recent instrument launches and sketching out potential future directions for their businesses.

A number of presentations touched on the continuing rise of clinical mass spec, with Danaher, Agilent, and Bruker discussing efforts to move various systems into the clinic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.